The effect of positive expiratory pressure breathing, alone and in combination with coughing, was investigated in eight patients with cystic fibrosis. Functional residual capacity and total lung capacity was measured with a body plethysmograph before, during, and immediately after breathing with expiratory pressure of 5 and 15 cm H20, and after a coughing period. The positive expiratory pressure breathing was carried out five times for two minutes with a two minute interval between each period. Mucus transport was measured in a peripheral lung region and over the whole lung by a radioactive aerosol tracer technique. Clearance measurements were carried out continuously during positive expiratory pressure breathing and during a control period. Two minutes' breathing with an expiratory pressure of 5 and 15 cm H2O caused an increase in mean (SEM) functional residual capacity from 2-6 (0-1) to 3-6 (0-3) and 4-4 (0-5) 1 and an increase in total lung capacity from 5-1 (0-2) to 5-9 (0-3) and 6-9 (0-4) 1. Lung volumes were higher during breathing with an expiratory pressure of 15 cm H20 than with 5 cm H20; both returned to baseline values immediately after positive expiratory pressure breathing.
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The effect of positive expiratory pressure breathing, alone and in combination with coughing, was investigated in eight patients with cystic fibrosis. Functional residual capacity and total lung capacity was measured with a body plethysmograph before, during, and immediately after breathing with expiratory pressure of 5 and 15 cm H20, and after a coughing period. The positive expiratory pressure breathing was carried out five times for two minutes with a two minute interval between each period. Mucus transport was measured in a peripheral lung region and over the whole lung by a radioactive aerosol tracer technique. Clearance measurements were carried out continuously during positive expiratory pressure breathing and during a control period. Two minutes' breathing with an expiratory pressure of 5 and 15 cm H2O caused an increase in mean (SEM) functional residual capacity from 2-6 (0-1) to 3-6 (0-3) and 4-4 (0-5) 1 and an increase in total lung capacity from 5-1 (0-2) to 5-9 (0-3) and 6-9 (0-4) 1. Lung volumes were higher during breathing with an expiratory pressure of 15 Positive expiratory pressure breathing has been used in patients with chronic airflow obstruction,'6 in an attempt to improve ventilation and reduce mucus retention, and has been introduced more recently for patients with cystic fibrosis.7 A face mask is usually used with an inspiratory tube, containing a one way valve, and a variable expiratory resistance, resulting in a positive expiratory pressure throughout expiration of 5 or 15 cm H20. Application of positive expiratory pressure breathing to patients with cystic fibrosis is based on the hypothesis that mucus in peripheral small airways will be mobilised by coughing or a forced expiration if alveolar pressure is increased. Two mechanisms might lead to an increased volume of air behind mucus plugs during positive expiratory pressure breathing and thus to an increase in pressure in closed alveoli: an increase in intrabronchial pressure, which increases the pressure gradient between open and closed alveoli, and an increase in functional residual capacity, which reduces the resistance in collateral and small airways.89
The results of earlier studies on the effect of positive expiratory pressure breathing in patients with cystic fibrosis are contradictory. Some studies suggest that physiotherapy, including positive expiratory pressure breathing, leads to more mucus expectoration than conventional physiotherapy;7 but other studies have failed to confirm this."1'2 Some authors have shown that physiotherapy that includes positive expiratory pressure breathing improves lung function in patients with cystic fibrosis,7 1314 and arterial blood gas values improved in one study of patients with various disorders'5 but not in others.1' '2 16 There are no data on the effect of positive expiratory pressure breathing on lung function and mucus clearance in these patients.
If positive expiratory pressure breathing increases alveolar pressure behind mucus plugs by increasing the amount of gas in closed parts of the lungs, it should lead to an increase of thoracic gas volunie (TGV) that lasts some time after positive expiratory pressure breathing has ceased. Mucus plugs may subsequently be mobilised more effectively by forced expirations and coughing, after which TGV should return to its baseline value.
The purpose of our study was to determine whether positive expiratory pressure breathing increases thoracic gas volume, and whether any increase in lung volume is associated with increased mucus clearance rates during positive expiratory pressure breathing. We examined two expiratory pressures followed by a coughing period. 20 minute positive expiratory pressure breathing session, carbon dioxide production and oxygen uptake were calculated from mixed expiratory gas concentration and minute volume, using automatic equipment (Jager Eos Sprint).
MUCUS CLEARANCE MEASUREMENTS
Mucus clearance was measured as described previously.'920 Briefly, a heterodisperse aerosol was produced by an intermittent positive pressure respirator (Bennet AP-5), with 35-50 MBq technetium-99m labelled tin colloid (Amersham). Before inhalation of the aerosol peak expiratory flow (PEF) was measured to ensure that the degree of airflow obstruction was similar on the different days of measurement, as airflow obstruction influences the aerosol deposition pattern.2'22 After 40 inhalations 10-15% of the tracer was deposited in the airways. A gamma camera was situated behind the patient's thorax and connected to a computer for continuous acquisition of one minute frames over 45 minutes.
The initial deposition pattem was quantified by expressing the amount of radioactive tracer in the peripheral region of the lung as a percentage of whole lung deposition. The decreases in radioactivity in the peripheral region and in the whole lung region over 30 and 45 minutes were analysed. The interval between the end of the mucus clearance measurement and the beginning of the lung function tests was about 45 minutes.
The protocols were as follows: Protocol A (1) Mucus clearance was measured continuously for 45 minutes, with the patient supine. In the period from 30 to 35 minutes the patient was asked to cough every 30 seconds as productively as possible. (2) Spirometric values and lung volumes were determined before and immediately after the coughing period. Protocol B (1) Mucus clearance measurements were made as before but in the period from 10 to 30 minutes the patient breathed intermittently through a PEP mask with an expiratory pressure of 5 cm H20, breathing through the PEP mask for two minutes, followed by two minutes of undisturbed breathing; this was repeated five times. The patient was then asked to cough as productively as possible every 30 seconds for a further five minutes. (2) Spirometric values and lung volumes were determined before and after the PEP mask breathing. The patient, sitting in the body plethysmograph, breathed through the PEP mask (connected to the mouthpiece of the body plethysmograph) for two minutes. During and immediately after this period of PEP mask breathing TGVTLc and TGVFRC were measured. The patient then breathed again through the PEP mask for two minutes, followed by two minutes without the mask; this was repeated four times. TGVFRc and TGVTLC were measured in each period between the PEP mask breathing. Finally the patient was asked to cough every 30 seconds, as productively as possible, for five minutes. Protocol C This was identical to protocol B except that the expiratory pressure of the PEP mask was 15 cm H20. In five patients, carbon dioxide production and oxygen uptake were measured continuously during a third 20 minute positive expiratory pressure breathing session, which was performed after protocol C. The patient, seated, breathed through a PEP mask with an expiratory pressure of 15 cm H20 for two minutes, followed by two minutes of undisturbed breathing; this was repeated five times. (5) .
Neither peripheral mucus clearance nor whole lung mucus Yclearance at 30 minutes differed significantly after positive expiratory pressure breathiiig in protocols B and C from clearance during the same period without treatment (protocol A), mean (SEM) % peripheral clearance being for A 6 (1), B 8 (1), and C 5 (2), and mean (SEM) % whole lung clearance A 8 (2), B 10 (2), C 6 (2). There were also no significant differences in mucus clearance at 45 minutes between the three protocols after inclusion of the five minutes of coughing, mean (SEM) % peripheral clearance being for A 9 (2), B 10 (2), and C 11 (4) , and mean (SEM) % whole lung clearance A 11 (3), B 13 (2) , and C 13 (3 Obstructed areas are thought to reopen as a result of increased collateral ventilation.8 Falk et ali suggested that this might occur in patients with cystic fibrosis, mucus possibly being mobilised from peripheral small airways.
All patients in our study tolerated positive expiratory pressure breathing well. This was confirmed by our observation in five patients that the respiratory quotient, though increased at rest, remained stable during a 20 minute positive expiratory pressure breathing session with an expiratory pressure of 15 cm H20.
Some patients used the PEP mask as part of their respiratory physiotherapy at home and they reported, spontaneously or on being questioned, subjective improvement after positive expiratory pressure breathing, especially with the expiratory pressure of 15 cm H20. This subjective improvement supports our impression that compliance seems to be better for positive expiratory pressure breathing than for other respiratory physiotherapy measures. Surprisingly, none of the patients claimed a specific improvement in expectoration after positive expiratory pressure breathing, either at home or during our study.
Each protocol in our study was carried out twice with an interval of 45 minutes. Lung function was always measured during the second session. As lung function has been shown to return to baseline within 15 minutes of physiotherapy,'4 including positive expiratory pressure breathing, we think that it is valid to compare the two protocol sessions. The results of our study show that positive expiratory pressure breathing in patients with cystic fibrosis increases TGVFRC, even when the expiratory pressure is lower than that usually recommended by physicians and physiotherapists, and also lower than that used in other investigations." 1116 The increase in TGVFRc and TGVTLc was related to the expiratory pressure. The increase of TGVTLC during positive expiratory pressure breathing is possibly due to the opening up of collateral pathways or small airways in obstructed parts of the lungs as a result of an increased end expiratory volume.29 Our investigations show that increasing lung volume for short periods does not lead to improvement in spontaneous mucus transport or mucus transport induced by coughing. The latter may be because TGV returned to baseline values immediately after positive expiratory pressure breathing. If obstructed parts of the lungs are opened by positive expiratory pressure breathing they appear to collapse again immediately afterwards, probably as a result of anatomical changes in the lungs. Coughing is unlikely therefore to be influenced by positive expiratory pressure breathing.
We observed no significant change in the volume of trapped gas after the three protocols. The increase in lung volumes during positive expiratory pressure breathing in our study may reduce unequal ventilation and lead to an improvement in arterial blood gas tensions, as was found by Herala et al. '5 It is uncertain whether these short term improvements in arterial blood gases are clinically important in patients with cystic fibrosis but they may explain the subjective improvement claimed by our patients.
Another type of positive expiratory pressure breathing has been described by Oberwaldner et al'0 and may be more effective, though the expiratory pressures of more than 60 cm H20 used by these authors may cause complications. In this technique the patient is asked to expire forcefully through a PEP mask with an expiratory resistance; the patient is therefore "coughing" at a time when some parts of the lungs should be reopened by increased collateral ventilation, thus mobilising mucus plugs in small airways.
Our study in patients with cystic fibrosis has shown that positive expiratory pressure breathing for two minutes on five occasions temporarily increases lung volume, but this does not improve mucus transport. 
